JM
Indaptus Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| INDP-101 | Advanced Solid Tumors | Phase 1 |
Leadership Team at Indaptus Therapeutics
MJ
Michael J. Newman
Founder, President, and Chief Scientific Officer
RJ
Roger J. Waltzman
Chief Medical Officer
| Drug | Indication | Phase |
|---|---|---|
| INDP-101 | Advanced Solid Tumors | Phase 1 |